← Leaderboards
Jatinder K. Lamba
University Of Florida
$4,761,475
Attributed
$7,826,129
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,826,129 · 4
By mechanism
R01$7,270,034 · 2
R21$438,897 · 1
U54$117,198 · 1
Top collaborators
- Stanley Barrett Pounds17 shared
- Roland Bruno Walter3 shared
Most similar at University Of Florida
Same institution · by research overlap
- Stanley Barrett Pounds$2,845,206
- Raymond B Mailhot$294,796
- Erin M Mobley$294,796
Others in their field
Top investigators on “Chemotherapy”
- George R Seage · Abt Associates, Inc.$223,371,661
- Charles A Coltman · Southwest Oncology Group$170,244,220
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Peter C Adamson · National Childhood Cancer Foundation$154,566,243
- Philip J Disaia · University Of California Irvine$115,055,799
- Norman Wolmark · Nsabp Foundation, Inc.$106,367,723
Research focus
ChemotherapyChildhood LeukemiaAra-CLeukemic CellCell LineS Research HospitalSaint Jude Children&AposChildhood Acute Myeloid LeukemiaGenesIn VitroGene ExpressionPharmacogeneticsGenomicsVariantEvaluationEnrollmentClinical TrialsResearch PersonnelCohortMolecularPrognosticBiologicalMethylationCollaborations
Grant awards (27)
Integrated Systems Biology of Pediatric AML$665,466
R01 · FY2025 · CA · contact PI
Genomics of AML Prognosis$379,286
R01 · FY2025 · CA · contact PI
Research Education Core$117,198
U54 · FY2025 · CA · contact PI
Genomics of AML Prognosis$79,819
R01 · FY2025 · CA · contact PI
Integrated Systems Biology of Pediatric AML$636,388
R01 · FY2024 · CA · contact PI
Genomics of AML Prognosis$360,324
R01 · FY2024 · CA · contact PI
Genomics of AML Prognosis$75,828
R01 · FY2024 · CA · contact PI
Integrated Systems Biology of Pediatric AML$693,955
R01 · FY2023 · CA · contact PI
Genomics of AML Prognosis$379,292
R01 · FY2023 · CA · contact PI
Genomics of AML Prognosis$79,819
R01 · FY2023 · CA · contact PI
Genomics of AML Prognosis$371,709
R01 · FY2022 · CA · contact PI
Genomics of AML Prognosis$404,235
R01 · FY2021 · CA · contact PI
Pharmacogenomics of Ara-C in AML$310,602
R01 · FY2018 · CA · contact PI
Pharmacogenomics of Ara-C in AML$310,602
R01 · FY2017 · CA · contact PI
Pharmacogenomics of Ara-C in AML$310,509
R01 · FY2016 · CA · contact PI
Pharmacogenomics of Ara-C in AML$304,007
R01 · FY2015 · CA · contact PI
Pharmacogenomics of Ara-C in AML$322,539
R01 · FY2014 · CA · contact PI
Pharmacogenomics of Ara-C in AML$6,032
R01 · FY2014 · CA · contact PI
Impact of genetic variation on response to GO therapy in COG-AML clinical trials$107,877
R21 · FY2013 · CA · contact PI
Impact of genetic variation on response to GO therapy in COG-AML clinical trials$86,333
R21 · FY2013 · CA · contact PI
Pharmacogenetics of Ara-C Metabolic Pathway$277,663
R01 · FY2012 · CA · contact PI
Impact of genetic variation on response to GO therapy in COG-AML clinical trials$244,687
R21 · FY2012 · CA · contact PI
Pharmacogenetics of Ara-C Metabolic Pathway$277,663
R01 · FY2011 · CA · contact PI
Pharmacogenetics of Ara-C Metabolic Pathway$286,251
R01 · FY2010 · CA · contact PI
Pharmacogenetics of Ara-C Metabolic Pathway$299,001
R01 · FY2009 · CA · contact PI
Pharmacogenetics of Ara-C Metabolic Pathway$92,000
R01 · FY2009 · CA · contact PI
Pharmacogenetics of Ara-C Metabolic Pathway$347,044
R01 · FY2008 · CA · contact PI